Member Info for Parob

Hi TwoGood2Die,

I’m suggesting 7p+ over the next few trading days as the stock was technically oversold due to Sneller selling 8%+ shares and now they’ve been cleared this should snap back up to where it would have been had he not

sold. Technical movements don’t require news, but any good news will give this a much bigger boost.

Almost 1% of all shares in issue bought today.

Highest close in two weeks.

It appears the overhang from Sneller has now fully cleared.

Astute investors have been picking up cheap shares over the past couple of weeks whilst the sp has consolidated below and around 5p.

This is just the start of the recovery imo. Over the next few trading days I’m expecting decent volume and the sp to race back towards 7p+.

Bumblebee1,

The price ticked up at 8.05am, the time of the buy, so I’m certain it’s a buy. This stock doesn’t have much attention at the moment, but some decent daily gains from these lows and that will change imo.

Surely this is an institution taking advantage of the price down here.

Almost 0.5% of shares in issue bought this morning so far.

There was a 510K sale on Friday and I get the impression that’s the last block from the seller as it’s moving up freely now.

Looks to me like the market makers are still clearing the remaining overhang from Sneller’s (8%+) sells, hence the consolidation around the 5p mark.

Should start moving up pretty quickly imo once they’re cleared and I don’t think we have too long to wait now.

Great to see them increasing and I doubt they will stop at 13% especially whilst the sp is this low.

Good to see others seeing value at this level.

Hopefully see LionTrust do the same.

Worth watching this video with Twin Petes Investing. CREO mentioned from 35 mins in.

https://www.youtube.com/watch?v=vvvHAjV2ywQ&t=3610s&pp=2AGaHJACAQ%3D%3D

Discussion/speculation that Intuitive (a behemoth) who CREO have a multi-year agreement with could be a potential acquirer of CREO.

https://creomedical.com/latest_news/collaboration-agreement-with-intuitive/

Perhaps an institution taking advantage of the low price under recent Director buys. I mean LionTrust were buying only 2 months ago and they were aware some NHS contracts were on hold then, hence already priced in.

Watching for TR1s

Barchild,

Simon obvious has confidence at these levels. He’s spent about £80K since the interims on shares.

Hopefully another big blue day as the shares recover to a more sensible market cap.

BUY SIGNAL generated today on British Bulls.

“We may be at a market bottom or at the start of a reaction rally.”

https://www.britishbulls.com/SignalPage.aspx?lang=en&Ticker=TLY.L

Simon Stilwell, a Non-Executive Director and Chairman Designate of Totally, purchased 1M shares on the 29th Nov at 6.09p, so current sp still offering a decent discount to that level.

Hopefully we have an institution increasing. If it is, that will really speed up the sp recovery to a more sensible level.

I think it could be Liontrust as they were increasing just 2 months ago and a lot of the bad news (loss of contracts etc) was already known then.

As I have mentioned on the advfn bb, this is a trade for me at this stage but I will re-assess depending on newsflow and price action.

I like to buy when negativity is at its peak.

IMO Sneller has provided a nice trading opportunity here, but each to their own.

7.2p is my current target price.

Redinjun,

I entered over the last 2 trading days (at 4.7 and 4.3) with an average at 4.5p.

I’ve been watching for months and took the plunge when it was obvious a large seller was offloading causing the market cap to drop to what I consider a ridiculously cheap level. The results weren’t great but didn’t warrant such a huge drop, and the sp would probably have dipped to 7-7.5p following the interims if it hadn’t been for the large seller. Much of the bad news was already priced in. A 12M chunk was sold last week and then a 3.6M block delayed sell showed up today from Friday, totalling 15.6M. Sneller’s last TR1 showed he held 8.99%, 17.6M shares, but it’s highly possible he continued to sell down to 8% (without having to notify) which equals 15.68M, so you can see how I deduced it was him!

I think this will recover quickly from this price now he’s out. The stock is very oversold technically so I’m expecting a very strong bounce.

Just waiting for the TR1 now which will attract more attention to the stock.

99% sure its Sneller who has been selling and he’s now out.

Https://www.fiercebiotech.com/biotech/glaxosmithkline-and-archemix-form-strategic-alliance-to-develop-aptamers-to-treat

Link didn’t work in last post

https://www.pharmatimes.com/news/gsk_aptamer_deal_with_archemix_could_be_worth_$1.4_billion_986116

Jona35,

I take it this is the tweet you’re referring to?

https://x.com/aptamergroup/status/1701144269468103018?s=46&t=_ybVnpe01AP_F1Pw0JqKTg

Also worth noting is this deal in the Aptamer space from 2008, but shows the vast potential on offer against current market cap.

GSK aptamer deal with Archemix could be worth $1.4 billion

23rd December 2008

https://www.pharmatimes.com/news/gsk_aptamer_deal_with_archemix_could_be_worth_$1.4_billion_986116

Yet again, an excellent find 2phevs! Thank you for updating us all here. I’ve a shared on advfn with credit to you of course.

Cheers